Authors:
Braun-Dullaeus, RC
Mann, MJ
Seay, U
Zhang, LN
von der Leyen, HE
Morris, RE
Dzau, VJ
Citation: Rc. Braun-dullaeus et al., Cell cycle protein expression in vascular smooth muscle cells in vitro andin vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin, ART THROM V, 21(7), 2001, pp. 1152-1158
Citation: A. Ehsan et al., Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide genetherapy, J THOR SURG, 121(4), 2001, pp. 714-722
Citation: Vj. Dzau et al., Gene therapy and genomic strategies for cardiovascular surgery: The emerging field of surgiomics, J THOR SURG, 121(2), 2001, pp. 206-216
Authors:
von der Leyen, HE
Braun-Dullaeus, R
Mann, MJ
Zhang, LN
Niebauer, J
Dzau, VJ
Citation: He. Von Der Leyen et al., A pressure-mediated nonviral method for efficient arterial gene and oligonucleotide transfer, HUM GENE TH, 10(14), 1999, pp. 2355-2364
Authors:
Mann, MJ
Whittemore, AD
Donaldson, MC
Belkin, M
Conte, MS
Polak, JF
Orav, EJ
Ehsan, A
Dell'Acqua, G
Dzau, VJ
Citation: Mj. Mann et al., Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial, LANCET, 354(9189), 1999, pp. 1493-1498
Citation: Mj. Mann et al., Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues, P NAS US, 96(11), 1999, pp. 6411-6416
Authors:
Braun-Dullaeus, RC
Mann, MJ
Ziegler, A
von der Leyen, HE
Dzau, VJ
Citation: Rc. Braun-dullaeus et al., A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy, J CLIN INV, 104(6), 1999, pp. 815-823